Finanzen von Rxsight Inc (RXST)RXSTRxsight Inc

Evaluating the bottom line, RxSight, Inc. maintains a gross margin of 76.72%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -40.81%, while the net margin is -35.85%. These profitability ratios, combined with a Return on Equity (ROE) of -17.35%, provide a clear picture of how effectively RXST converts its operational activities into shareholder value.

In the context of the broader market, RXST competes directly with industry leaders such as OPTX and SHMD. With a market capitalization of $293.23M, it holds a significant position in the sector. When comparing efficiency, RXST's gross margin of 76.72% stands against OPTX's 25.90% and SHMD's 23.93%. Such benchmarking helps identify whether RxSight, Inc. is trading at a premium or discount relative to its financial performance.

RxSight has shown fluctuating revenue, with Q2 2026 revenue at $33.7 million, down 19% year-over-year. The gross margin remains strong at 76.72%, but the company has reported consistent net losses, with a net loss of $12.1 million in Q2 2026.